Table 4 Adverse events after DEB-TACE.

From: Transarterial chemoembolization of unresectable renal cell carcinoma with doxorubicin-loaded CalliSpheres drug-eluting beads

Variables

Grade 1

Grade 2

 ≥ Grade 3

Abdominal distension

2 (5.7%)

2 (5.7%)

0 (0.0%)

Abdominal pain

6 (17.1%)

6 (17.1%)

0 (0.0%)

Nausea or vomiting

3 (8.6%)

2 (5.7%)

0 (0.0%)

Hematuria

1 (2.9%)

0 (0.0%)

0 (0.0%)

Fever

2 (5.7%)

1 (2.9%)

0 (0.0%)

Back to article page